A detailed history of Profund Advisors LLC transactions in Illumina, Inc. stock. As of the latest transaction made, Profund Advisors LLC holds 14,697 shares of ILMN stock, worth $2.1 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
14,697
Previous 15,623 5.93%
Holding current value
$2.1 Million
Previous $1.63 Million 17.55%
% of portfolio
0.07%
Previous 0.06%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$105.28 - $135.9 $97,489 - $125,843
-926 Reduced 5.93%
14,697 $1.92 Million
Q2 2024

Aug 13, 2024

BUY
$101.05 - $133.57 $158,749 - $209,838
1,571 Added 11.18%
15,623 $1.63 Million
Q1 2024

May 08, 2024

SELL
$127.73 - $147.2 $121,854 - $140,428
-954 Reduced 6.36%
14,052 $1.93 Million
Q4 2023

Feb 14, 2024

BUY
$92.79 - $142.53 $237,542 - $364,876
2,560 Added 20.57%
15,006 $2.09 Million
Q3 2023

Nov 13, 2023

BUY
$128.91 - $192.44 $386,601 - $577,127
2,999 Added 31.75%
12,446 $1.71 Million
Q2 2023

Aug 10, 2023

BUY
$183.43 - $232.67 $96,484 - $122,384
526 Added 5.9%
9,447 $1.77 Million
Q1 2023

May 11, 2023

SELL
$193.75 - $232.55 $3.22 Million - $3.86 Million
-16,617 Reduced 65.07%
8,921 $2.07 Million
Q4 2022

Feb 02, 2023

BUY
$187.24 - $242.74 $46,810 - $60,685
250 Added 0.99%
25,538 $5.16 Million
Q3 2022

Nov 04, 2022

SELL
$177.23 - $227.44 $231,285 - $296,809
-1,305 Reduced 4.91%
25,288 $4.83 Million
Q2 2022

Aug 01, 2022

SELL
$181.58 - $368.0 $650,419 - $1.32 Million
-3,582 Reduced 11.87%
26,593 $4.9 Million
Q1 2022

May 10, 2022

SELL
$303.87 - $423.8 $1.76 Million - $2.46 Million
-5,807 Reduced 16.14%
30,175 $10.5 Million
Q4 2021

Feb 08, 2022

SELL
$347.28 - $421.83 $968,216 - $1.18 Million
-2,788 Reduced 7.19%
35,982 $13.7 Million
Q3 2021

Nov 12, 2021

BUY
$405.61 - $524.84 $388,574 - $502,796
958 Added 2.53%
38,770 $15.7 Million
Q2 2021

Aug 12, 2021

SELL
$372.84 - $481.5 $394,837 - $509,908
-1,059 Reduced 2.72%
37,812 $17.9 Million
Q1 2021

May 14, 2021

SELL
$361.28 - $504.76 $363,447 - $507,788
-1,006 Reduced 2.52%
38,871 $14.9 Million
Q4 2020

Feb 09, 2021

BUY
$292.7 - $370.96 $869,319 - $1.1 Million
2,970 Added 8.05%
39,877 $14.8 Million
Q3 2020

Nov 13, 2020

SELL
$268.51 - $400.74 $1.39 Million - $2.08 Million
-5,187 Reduced 12.32%
36,907 $11.4 Million
Q2 2020

Aug 03, 2020

BUY
$256.46 - $373.01 $1.34 Million - $1.95 Million
5,234 Added 14.2%
42,094 $15.6 Million
Q1 2020

May 15, 2020

SELL
$209.2 - $335.53 $2.58 Million - $4.13 Million
-12,310 Reduced 25.04%
36,860 $10.1 Million
Q4 2019

Feb 18, 2020

BUY
$288.29 - $335.49 $1.44 Million - $1.67 Million
4,981 Added 11.27%
49,170 $16.3 Million
Q3 2019

Nov 12, 2019

SELL
$266.84 - $378.23 $663,097 - $939,901
-2,485 Reduced 5.32%
44,189 $13.4 Million
Q2 2019

Aug 13, 2019

SELL
$300.59 - $368.15 $1.13 Million - $1.38 Million
-3,759 Reduced 7.45%
46,674 $17.2 Million
Q1 2019

May 15, 2019

BUY
$272.57 - $321.18 $216,420 - $255,016
794 Added 1.6%
50,433 $15.7 Million
Q4 2018

Feb 14, 2019

SELL
$272.46 - $366.54 $3.31 Million - $4.45 Million
-12,143 Reduced 19.65%
49,639 $14.9 Million
Q3 2018

Nov 13, 2018

BUY
$279.04 - $367.06 $1.47 Million - $1.94 Million
5,283 Added 9.35%
61,782 $22.7 Million
Q2 2018

Aug 13, 2018

SELL
$228.17 - $292.07 $625,870 - $801,148
-2,743 Reduced 4.63%
56,499 $15.8 Million
Q1 2018

May 14, 2018

SELL
$209.54 - $253.91 $875,667 - $1.06 Million
-4,179 Reduced 6.59%
59,242 $14 Million
Q4 2017

Feb 14, 2018

SELL
$202.23 - $230.03 $1.34 Million - $1.52 Million
-6,629 Reduced 9.46%
63,421 $13.9 Million
Q3 2017

Nov 13, 2017

BUY
$172.3 - $213.93 $829,624 - $1.03 Million
4,815 Added 7.38%
70,050 $14 Million
Q2 2017

Aug 11, 2017

BUY
N/A
65,235
65,235 $11.3 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22.5B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Profund Advisors LLC Portfolio

Follow Profund Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.